CVE-2026-50557
Multiple vulnerabilities have been discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation, and remote denial of service.
CSIRTS triage
- What
- Multiple vulnerabilities allow an attacker to cause remote arbitrary code execution, privilege escalation, and remote denial of service.
- Who is affected
- Deployments of IBM products are affected.
- Urgency
- Remediation is critical due to the severity of the vulnerabilities, including remote code execution, though exploitation status is currently unknown.
- Action
- Users should update their IBM products to the latest version.
AI-assisted analysis generated from the source advisory — verify against the original.
⚡ Watch CVE-2026-50557
Get an email if CVE-2026-50557 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.
Exploitation outlook
- Low exploitation risk0.20% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 10% of all EPSS-scored CVEs.
Advisory coverage (2)
- unknownMultiple vulnerabilities in IBM products (July 24, 2026)cert-fr-avis · 2026-07-24
- mediumGHSA-f3m7-gqxr-g87x: Angular: Template and Attribute Namespace Sanitization Bypass (XSS)ghsa · 2026-06-15
External references
Embed the live status
— this badge updates automatically when the KEV or exploit status changes. How to embed it →
[](https://www.csirts.com/cve/CVE-2026-50557)